PPA
Parametric Portfolio Associates Portfolio holdings
AUM
$190B
1-Year Return
18.53%
This Quarter Return
+11.37%
1 Year Return
+18.53%
3 Year Return
+86.89%
5 Year Return
+137.96%
10 Year Return
–
AUM
$195B
AUM Growth
+$19.5B
(+11%)
Cap. Flow
+$3.08B
Cap. Flow
% of AUM
1.58%
Top 10 Holdings %
Top 10 Hldgs %
24.02%
Holding
3,778
New
180
Increased
2,074
Reduced
1,352
Closed
151
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$856M |
| 2 |
Tesla
TSLA
|
+$229M |
| 3 |
Microsoft
MSFT
|
+$168M |
| 4 |
Apple
AAPL
|
+$155M |
| 5 |
Amazon
AMZN
|
+$153M |
Top Sells
| 1 |
Vanguard Russell 1000 Value ETF
VONV
|
+$645M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$189M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$151M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$118M |
| 5 |
Medtronic
MDT
|
+$88.7M |
Sector Composition
| 1 | Technology | 25.14% |
| 2 | Financials | 12.69% |
| 3 | Healthcare | 12.46% |
| 4 | Consumer Discretionary | 10.99% |
| 5 | Communication Services | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
BlackRock Municipal Income Trust
BFK
$436M
| $200K | ﹤0.01% |
12,880
-46,799
| -78% | -$727K |
|
3427
Blue Foundry Bancorp
BLFY
$203M
| $200K | ﹤0.01% |
+13,694
| New | +$200K |
|
3428
MiMedx Group
MDXG
$1.06B
| $200K | ﹤0.01% |
33,042
-1,050
| -3% | -$6.36K |
|
3429
Spyre Therapeutics
SYRE
$1B
| $199K | ﹤0.01% |
1,679
-125
| -7% | -$14.8K |
|
|
VIEW
3430
DELISTED
View, Inc. Class A Common Stock
VIEW
| $197K | ﹤0.01% |
840
+630
| +300% | +$148K |
|
3431
Solid Biosciences
SLDB
$399M
| $196K | ﹤0.01% |
7,485
+4,257
| +132% | +$111K |
|
3432
Precigen
PGEN
$1.24B
| $194K | ﹤0.01% |
52,167
-83,220
| -61% | -$309K |
|
3433
Teekay
TK
$734M
| $194K | ﹤0.01% |
61,940
-22,461
| -27% | -$70.3K |
|
3434
Fidelity MSCI Energy Index ETF
FENY
$1.42B
| $191K | ﹤0.01% |
+12,615
| New | +$191K |
|
3435
Xeris Biopharma Holdings
XERS
$1.25B
| $191K | ﹤0.01% |
+65,090
| New | +$191K |
|
3436
Comscore
SCOR
$31.8M
| $190K | ﹤0.01% |
2,846
+219
| +8% | +$14.6K |
|
3437
UroGen Pharma
URGN
$991M
| $189K | ﹤0.01% |
19,912
-51,133
| -72% | -$485K |
|
3438
Treace Medical Concepts
TMCI
$449M
| $188K | ﹤0.01% |
10,082
-6,585
| -40% | -$123K |
|
3439
Accuray
ARAY
$175M
| $186K | ﹤0.01% |
38,951
+5,465
| +16% | +$26.1K |
|
|
AZRE
3440
DELISTED
Azure Power Global Limited
AZRE
| $186K | ﹤0.01% |
10,275
-5,568
| -35% | -$101K |
|
3441
Babcock & Wilcox
BW
$218M
| $185K | ﹤0.01% |
20,468
+3,422
| +20% | +$30.9K |
|
3442
Mersana Therapeutics
MRSN
$35.1M
| $184K | ﹤0.01% |
1,183
-160
| -12% | -$24.9K |
|
|
LTRPA
3443
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $182K | ﹤0.01% |
83,835
+3,591
| +4% | +$7.8K |
|
3444
CytomX Therapeutics
CTMX
$360M
| $181K | ﹤0.01% |
41,761
+353
| +0.9% | +$1.53K |
|
|
OMIC
3445
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $181K | ﹤0.01% |
523
-735
| -58% | -$254K |
|
|
TTCF
3446
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $181K | ﹤0.01% |
+11,640
| New | +$181K |
|
3447
KALA BIO
KALA
$102M
| $180K | ﹤0.01% |
2,971
+595
| +25% | +$36K |
|
3448
Bioventus
BVS
$482M
| $179K | ﹤0.01% |
+12,355
| New | +$179K |
|
3449
Natural Gas Services Group
NGS
$326M
| $178K | ﹤0.01% |
16,978
-487
| -3% | -$5.11K |
|
3450
Omeros
OMER
$287M
| $177K | ﹤0.01% |
27,520
-4,776
| -15% | -$30.7K |
|